{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:10Z","timestamp":1776816010208,"version":"3.51.2"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T00:00:00Z","timestamp":1683590400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Introduction:<\/jats:bold> Asparagus (<jats:italic>Asparagus officinalis<\/jats:italic>) is a perennial flowering plant species. Its main components have tumor-prevention, immune system-enhancement, and anti-inflammation effects. Network pharmacology is a powerful approach that is being applied increasingly to research of herbal medicines. Herb identification, study of compound targets, network construction, and network analysis have been used to elucidate how herbal medicines work. However, the interaction of bioactive substances from asparagus with the targets involved in multiple myeloma (MM) has not been elucidated. We explored the mechanism of action of asparagus in MM through network pharmacology and experimental verification.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> The active ingredients and corresponding targets of asparagus were acquired from the Traditional Chinese Medicine System Pharmacology database, followed by identification of MM-related target genes using GeneCards and Online Mendelian Inheritance in Man databases, which were matched with the potential targets of asparagus. Potential targets were identified and a target network of traditional Chinese medicine was constructed. The STRING database and Cytoscape were utilized to create protein\u2013protein interaction (PPI) networks and further screening of core targets.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> The intersection of target genes and core target genes of the phosphoinositide 3-kinase\/protein kinase B (PI3K\/AKT) pathway was enriched, the top-five core target genes were selected, and the binding affinity of corresponding compounds to the top-five core targets was analyzed using molecular docking. Network pharmacology identified nine active components of asparagus from databases based on oral bioavailability and drug similarity, and predicted 157 potential targets related to asparagus. Enrichment analyses showed that \u201csteroid receptor activity\u201d and the \u201cPI3K\/AKT signaling pathway\u201d were the most enriched biological process and signaling pathway, respectively. According to the top-10 core genes and targets of the PPI pathway, AKT1, interleukin (IL)-6, vascular endothelial growth factor (VEGF)A, MYC, and epidermal growth factor receptor (EGFR) were selected for molecular docking. The latter showed that five core targets of the PI3K\/AKT signaling pathway could bind to quercetin, among which EGFR, IL-6, and MYC showed strong docking, and the diosgenin ligand could bind to VEGFA. Cell experiments showed that asparagus, through the PI3K\/AKT\/NF-\u03baB pathway, inhibited the proliferation and migration of MM\u00a0cells, and caused retardation and apoptosis of MM\u00a0cells in the G0\/G1 phase.<\/jats:p><jats:p><jats:bold>Discussion:<\/jats:bold> In this study, the anti-cancer activity of asparagus against MM was demonstrated using network pharmacology, and potential pharmacological mechanisms were inferred using <jats:italic>in vitro<\/jats:italic> experimental data.<\/jats:p>","DOI":"10.3389\/fphar.2023.1076815","type":"journal-article","created":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T05:14:21Z","timestamp":1683609261000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["RETRACTED: Mechanism of action of Asparagus officinalis extract against multiple myeloma using bioinformatics tools, in silico and in vitro study"],"prefix":"10.3389","volume":"14","author":[{"given":"Yanju","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feiqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chike","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Zan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhixu","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jishi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongxin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,5,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"110909","DOI":"10.1016\/j.biopha.2020.110909","article-title":"EMT, cancer stem cells and autophagy; the three main axes of metastasis","volume":"133","author":"Babaei","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"B2","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/978-1-4939-7000-1_26","article-title":"Protein data bank (PDB): The single global macromolecular structure archive","volume":"1607","author":"Burley","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1136\/gutjnl-2018-315983","article-title":"Effect of huaier granule on recurrence after curative resection of HCC: A multicentre, randomised clinical trial","volume":"67","author":"Chen","year":"2018","journal-title":"Gut"},{"key":"B4","doi-asserted-by":"publisher","first-page":"3920","DOI":"10.7150\/jca.51407","article-title":"Asparagus Polysaccharide inhibits the Hypoxia-induced migration, invasion and angiogenesis of Hepatocellular Carcinoma Cells partly through regulating HIF1\u03b1\/VEGF expression via MAPK and PI3K signaling pathway","volume":"12","author":"Cheng","year":"2021","journal-title":"J. Cancer"},{"key":"B5","doi-asserted-by":"publisher","first-page":"9498","DOI":"10.1073\/pnas.150006697","article-title":"A role for transcriptional repression of p21CIP1 by c-Myc in overcoming transforming growth factor beta -induced cell-cycle arrest","volume":"97","author":"Claassen","year":"2000","journal-title":"Proc. Nat. Acad. Sci. U. S. A."},{"key":"B6","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1001\/jama.2022.0003","article-title":"Diagnosis and management of multiple myeloma: A review","volume":"327","author":"Cowan","year":"2022","journal-title":"JAMA"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.3390\/ijms20092340","article-title":"Emerging roles of C-myc in cancer stem cell-related signaling and resistance to cancer chemotherapy: A potential therapeutic target against colorectal cancer","volume":"20","author":"Elbadawy","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1126\/science.7997877","article-title":"Cell cycle control and cancer","volume":"266","author":"Hartwell","year":"1994","journal-title":"Science"},{"key":"B9","first-page":"682","article-title":"Effect of Baihe Gujin Decoction with TP chemotherapy on advanced non-small cell lung carcinoma differentiated by lung-kidney yin deficiency and on the immune function","volume":"15","author":"He","year":"2020","journal-title":"World J. Integr. Tradit. West. Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s12885-021-07833-5","article-title":"Diallyl thiosulfinate enhanced the anti-cancer activity of dexamethasone in the side population cells of multiple myeloma by promoting miR-127-3p and deactivating the PI3K\/AKT signaling pathway","volume":"21","author":"He","year":"2021","journal-title":"BMC cancer"},{"key":"B11","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jep.2018.12.033","article-title":"Exploring the multicomponent synergy mechanism of Banxia Xiexin Decoction on irritable bowel syndrome by a systems pharmacology strategy","volume":"233","author":"Li","year":"2019","journal-title":"J. Ethnopharmacol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1080\/10286020.2016.1206529","article-title":"Two new phenolic compounds and antitumor activities of asparinin A from Asparagus officinalis","volume":"19","author":"Li","year":"2017","journal-title":"J. Asian Nat. pro Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"862966","DOI":"10.3389\/fphar.2022.862966","article-title":"Combining network pharmacology and experimental validation to study the action and mechanism of water extract of Asparagus against colorectal cancer","volume":"13","author":"Liang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1186\/s12967-020-02468-9","article-title":"C6-ceramide treatment inhibits the proangiogenic activity of multiple myeloma exosomes via the miR-29b\/Akt pathway","volume":"18","author":"Liu","year":"2020","journal-title":"J. Transl. Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1002\/jcb.29383","article-title":"miR-215-5p is an anticancer gene in multiple myeloma by targeting RUNX1 and deactivating the PI3K\/AKT\/mTOR pathway","volume":"121","author":"Liu","year":"2020","journal-title":"J. cell Biochem."},{"key":"B16","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/BF02831393","article-title":"Expression of survivin, cyclinD1, p21(WAF1), caspase-3 in cervical cancer and its relation with prognosis","volume":"25","author":"Lu","year":"2005","journal-title":"J. Huazhong Univ. Sci. Technol. Med. Sci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e1406","DOI":"10.1634\/theoncologist.2020-0141","article-title":"Multiple myeloma incidence and mortality around the globe; interrelations between Health access and quality, economic resources, and patient empowerment","volume":"25","author":"Ludwig","year":"2020","journal-title":"Oncologist"},{"key":"B18","doi-asserted-by":"publisher","first-page":"4458","DOI":"10.1158\/0008-5472.CAN-13-3652","article-title":"Selective and potent Akt inhibition triggers anti-myeloma activities and enhances fatal endoplasmic reticulum stress induced by proteasome inhibition","volume":"74","author":"Mimura","year":"2014","journal-title":"Cancer Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1755-8794-2-18","article-title":"PrognoScan: A new database for meta-analysis of the prognostic value of genes","volume":"2","author":"Mizuno","year":"2009","journal-title":"BMC Med. genomics"},{"key":"B20","doi-asserted-by":"publisher","first-page":"117503","DOI":"10.1016\/j.lfs.2020.117503","article-title":"IGF-1 promotes multiple myeloma progression through PI3K\/Akt-mediated epithelial-mesenchymal transition","volume":"249","author":"Peng","year":"2020","journal-title":"Life Sci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"4331","DOI":"10.3390\/ijms20184331","article-title":"Molecular docking: Shifting paradigms in drug discovery","volume":"20","author":"Pinzi","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s10495-020-01601-9","article-title":"BCL-2 family deregulation in colorectal cancer: Potential for BH3 mimetics in therapy","volume":"25","author":"Ramesh","year":"2020","journal-title":"Apoptosis"},{"key":"B23","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1758-2946-6-13","article-title":"Tcmsp: A database of systems pharmacology for drug discovery from herbal medicines","volume":"6","author":"Ru","year":"2014","journal-title":"J. cheminform"},{"key":"B24","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.canlet.2018.06.020","article-title":"Pharmacologic inhibition of AKT leads to cell death in relapsed multiple myeloma","volume":"432","author":"Song","year":"2018","journal-title":"Cancer Lett."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2762","DOI":"10.1182\/blood-2002-09-2813","article-title":"CD40 induces human multiple myeloma cell migration via phosphatidylinositol 3-kinase\/AKT\/NF-kappa B signaling","volume":"101","author":"Tai","year":"2003","journal-title":"Blood"},{"key":"B26","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1046\/j.1365-2184.2003.00266.x","article-title":"The cell cycle: A review of regulation, deregulation and therapeutic targets in cancer","volume":"36","author":"Vermeulen","year":"2003","journal-title":"Cell Prolif."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1002\/jsfa.5922","article-title":"Saponins extracted from by-product of Asparagus officinalis L. suppress tumour cell migration and invasion through targeting Rho GTPase signalling pathway","volume":"93","author":"Wang","year":"2013","journal-title":"J. Sci. food Agric."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.1017\/erm.2018.3","article-title":"What has traditional Chinese medicine delivered for modern medicine","volume":"20","author":"Wang","year":"2018","journal-title":"Expert Rev. Mol. Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"783583","DOI":"10.3389\/fonc.2021.783583","article-title":"PIWIL1 drives chemoresistance in multiple myeloma by modulating mitophagy and the myeloma stem cell population","volume":"11","author":"Wang","year":"2022","journal-title":"Front. Oncol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"688461","DOI":"10.3389\/fonc.2021.688461","article-title":"Asparagus officinalis exhibits anti-tumorigenic and anti-metastatic effects in ovarian cancer","volume":"11","author":"Xu","year":"2021","journal-title":"Front. Oncol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1021\/acs.jafc.9b07103","article-title":"Asparanin A from Asparagus officinalis L. Induces G0\/G1 cell cycle arrest and apoptosis in human endometrial carcinoma ishikawa cells via mitochondrial and PI3K\/AKT signaling pathways","volume":"68","author":"Zhang","year":"2020","journal-title":"J. Agric. food Chem."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e41202","DOI":"10.1371\/journal.pone.0041202","article-title":"Prediction and analysis of the protein interactome in Pseudomonas aeruginosa to enable network-based drug target selection","volume":"7","author":"Zhang","year":"2012","journal-title":"PloS one"},{"key":"B33","doi-asserted-by":"publisher","first-page":"609705","DOI":"10.3389\/fimmu.2020.609705","article-title":"Research status and molecular mechanism of the traditional Chinese medicine and antitumor therapy combined strategy based on tumor microenvironment","volume":"11","author":"Zhang","year":"2021","journal-title":"Front. Immunol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3390\/nu8030156","article-title":"Dietary natural products for prevention and treatment of liver cancer","volume":"8","author":"Zhou","year":"2016","journal-title":"Nutrients"}],"updated-by":[{"DOI":"10.3389\/fphar.2025.1563699","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T00:00:00Z","timestamp":1737936000000}},{"DOI":"10.3389\/fphar.2025.1563699","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2025,1,26]],"date-time":"2025-01-26T00:00:00Z","timestamp":1737849600000},"record-id":"70208"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1076815\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T09:58:59Z","timestamp":1737971939000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1076815\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,9]]},"references-count":34,"alternative-id":["10.3389\/fphar.2023.1076815"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2023.1076815","relation":{"retraction":[{"id-type":"doi","id":"10.3389\/fphar.2025.1563699","asserted-by":"object"}]},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,9]]},"article-number":"1076815"}}